We cover a post by Dr. Rory Spiegel, EMNerd: The Case of Differing Perspectives), on the results of the ATACH-2 trial on blood pressure control in intracranial hemorrhage (ICH). This study sought to determine the safety and efficacy of the
Population: adults (>18 y/o) with ICH on CT scan, GCS ≥ 5 and
